REXO1L12P

Across TCGA pan-cancer cohorts, REXO1L12P RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated REXO1L12P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher REXO1L12P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated REXO1L12P expression acts as an unfavorable survival marker.

STAD are the cancer types where REXO1L12P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	II,III,IV	0.126	0.677	<.001	90	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

REXO1L12P–STAD (OS)

Open the STAD breakdown →